Obstetric antiphospholipid syndrome is not associated with an increased risk of subclinical atherosclerosis.


Journal

Rheumatology (Oxford, England)
ISSN: 1462-0332
Titre abrégé: Rheumatology (Oxford)
Pays: England
ID NLM: 100883501

Informations de publication

Date de publication:
01 Dec 2020
Historique:
received: 06 11 2019
revised: 18 02 2020
pubmed: 11 5 2020
medline: 27 1 2021
entrez: 11 5 2020
Statut: ppublish

Résumé

The persistent positivity of aPLs, either isolated or associated with thrombotic and/or obstetric events (APS), has been associated with the increase of intima-media thickness (IMT) and carotid plaques. Despite the fact that aPLs can promote both thrombotic and obstetric complications, some pathogenic differences have been documented between the two entities. This study aimed to evaluate whether the atherosclerotic risk differs between subjects with obstetric and thrombotic APS. A total of 167 APS women (36 obstetric and 131 thrombotic) were compared with 250 aPLs negative controls. IMT of the common carotid artery (CCA) and of the bulb and the prevalence of carotid plaques were assessed. CCA- and bulb-IMT were significantly higher in women with thrombotic APS, while being similar between the obstetric APS and the controls [CCA-IMT: mean (s.d.) 0.97 (0.49), 0.78 (0.22) and 0.81 (0.12) mm for the thrombotic, obstetric and control groups, respectively, P < 0.001 between thrombotic and controls, P = 0.002 between thrombotic and obstetric; bulb-IMT: mean (s.d.) 1.38 (0.79), 0.96 (0.27) and 0.96 (0.51) mm for the thrombotic, obstetric and control groups, P < 0.001]. Women with thrombotic APS had significantly increased risk of presenting carotid plaques. This risk was significantly lower in obstetric APS. Unlike thrombotic APS, obstetric APS is not associated with an increase of markers of subclinical atherosclerosis. If confirmed on wider populations, these results could suggest different pathogenetic role of aPLs in promoting atherosclerosis in vascular and obstetric APS, and raise questions on the risk-benefit profile of thromboprophylaxis in obstetric APS outside pregnancy periods.

Identifiants

pubmed: 32388557
pii: 5835407
doi: 10.1093/rheumatology/keaa116
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3709-3716

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Alessandra Bettiol (A)

Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA).

Giacomo Emmi (G)

Department of Experimental and Clinical Medicine, University of Firenze, Firenze.

Martina Finocchi (M)

Department of Experimental and Clinical Medicine, University of Firenze, Firenze.

Elena Silvestri (E)

Department of Experimental and Clinical Medicine, University of Firenze, Firenze.

Maria Letizia Urban (ML)

Department of Experimental and Clinical Medicine, University of Firenze, Firenze.

Irene Mattioli (I)

Department of Experimental and Clinical Medicine, University of Firenze, Firenze.

Antonella Scalera (A)

Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.

Roberta Lupoli (R)

Department of Translational Medical Sciences, Federico II University, Naples, Italy.

Alfredo Vannacci (A)

Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA).

Matteo Nicola Dario Di Minno (MND)

Department of Translational Medical Sciences, Federico II University, Naples, Italy.

Domenico Prisco (D)

Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH